- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01999140
Implantable Cardioverter Defibrillator (ICD Registry)
Study Overview
Status
Detailed Description
In January 2005 the Centers for Medicare and Medicaid Services (CMS) expanded the covered indications for primary prevention implantable cardioverter defibrillators (ICDs) to incorporate the findings from the Sudden Cardiac Death Heart Failure Trial (SCDHeFT) and the Multicenter Automatic Defibrillator Implantation Trial II (MADIT II). As part of this expansion, CMS mandated that a national registry be formed to compile data on Medicare patients implanted with primary prevention ICDs to confirm the appropriateness of ICD utilization in this patient population.
Responding to this mandate, a collaborative effort of the Heart Rhythm Society (HRS)and the American College of Cardiology Foundation (ACCF), utilizing the expertise of the National Cardiovascular Data Registry (NCDR®), developed the ICD Registry™. Enrollment opened on June 1, 2005. CMS selected the NCDR ICD Registry as the mandated national registry in October 2005.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: NCDR Product Support
- Phone Number: 1-800-257-4737
- Email: ncdr@acc.org
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20037
- Recruiting
- American College of Cardiology/National Cardiovascular Data Registry (NCDR)
-
Contact:
- NCDR Product Support
- Phone Number: 800-257-4737
- Email: ncdr@acc.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
All U.S and International patients.
Inclusion Criteria:
- All patients who receive an ICD/CRT-D (initial or generator change) for primary or secondary prevention purposes.
- All patients with an ICD/CRT-D undergoing a Lead Only procedure.
- U.S. populations must submit all patients who receive an ICD/CRT-D (initial or generator change) for primary prevention purposes who are insured by Medicare.
Exclusion Criteria:
None
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Primary prevention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Risk Adjusted Complications and Death Composite Measure
Time Frame: Post-procedure until discharge occurences. Reported quarterly based on a rolling 1 year of data.
|
Reported as one value for a composite measure looking at the following complications and death: Cardiac arrest, cardiac perforation, coronary venous dissection, hemothorax, device-related infection, lead dislodgement, mortality, myocardial infarction, pericardial tamponade, pneumothorax, stroke/transischemic attack (TIA), urgent cardiac surgery, hematoma, set screw problem
|
Post-procedure until discharge occurences. Reported quarterly based on a rolling 1 year of data.
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ICD Registry
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.